176 related articles for article (PubMed ID: 31107718)
1. In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.
Ito Y; Vertosick EA; Sjoberg DD; Vickers AJ; Al-Ahmadie HA; Chen YB; Gopalan A; Sirintrapun SJ; Tickoo SK; Eastham JA; Scardino PT; Reuter VE; Fine SW
Am J Surg Pathol; 2019 Aug; 43(8):1061-1065. PubMed ID: 31107718
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors associated with biochemical recurrence following radical prostatectomy for pathological T2 prostate cancer with negative surgical margins.
Aoun F; Albisinni S; Henriet B; Tombal B; Van Velthoven R; Roumeguère T
Scand J Urol; 2017 Feb; 51(1):20-26. PubMed ID: 27910728
[TBL] [Abstract][Full Text] [Related]
5. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
[TBL] [Abstract][Full Text] [Related]
6. The presence of prostate-specific antigen checked more than 1 year before diagnostic biopsy is an independent prognostic factor in patients undergoing radical prostatectomy.
Park SG; Shim KH; Choo SH; Kim SJ; Kim SI
Investig Clin Urol; 2021 Jul; 62(4):438-446. PubMed ID: 34085793
[TBL] [Abstract][Full Text] [Related]
7. Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy.
Marcq G; Michelet A; Hannink G; Rizk J; Sauvain J; Villers A; Saffarini M; Rochat CH
BMC Cancer; 2018 Dec; 18(1):1291. PubMed ID: 30587172
[TBL] [Abstract][Full Text] [Related]
8. Maximum tumor diameter adjusted to the risk profile predicts biochemical recurrence after radical prostatectomy.
Müller G; Rieken M; Bonkat G; Gsponer JR; Vlajnic T; Wetterauer C; Gasser TC; Wyler SF; Bachmann A; Bubendorf L
Virchows Arch; 2014 Oct; 465(4):429-37. PubMed ID: 25129371
[TBL] [Abstract][Full Text] [Related]
9. Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins.
Meyer CP; Hansen J; Boehm K; Tilki D; Abdollah F; Trinh QD; Fisch M; Sauter G; Graefen M; Huland H; Chun FK; Ahyai SA
World J Urol; 2017 Feb; 35(2):199-206. PubMed ID: 27260503
[TBL] [Abstract][Full Text] [Related]
10. Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer.
Song C; Kang T; Yoo S; Jeong IG; Ro JY; Hong JH; Kim CS; Ahn H
Urol Oncol; 2013 Feb; 31(2):168-74. PubMed ID: 21719325
[TBL] [Abstract][Full Text] [Related]
11. No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer.
Boehm K; Beyer B; Tennstedt P; Schiffmann J; Budaeus L; Haese A; Graefen M; Schlomm T; Heinzer H; Salomon G
World J Urol; 2015 Jun; 33(6):801-6. PubMed ID: 24989847
[TBL] [Abstract][Full Text] [Related]
12. Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men.
Assel MJ; Ulmert HD; Karnes RJ; Boorjian SA; Hillman DW; Vickers AJ; Klee GG; Lilja H
Prostate; 2020 Jan; 80(1):51-56. PubMed ID: 31603253
[TBL] [Abstract][Full Text] [Related]
13. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
14. The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.
Karl A; Buchner A; Tympner C; Kirchner T; Ganswindt U; Belka C; Ganzer R; Burger M; Eder F; Hofstädter F; Schilling D; Sievert K; Stenzl A; Scharpf M; Fend F; Vom Dorp F; Rübben H; Schmid K; Porres-Knoblauch D; Heidenreich A; Hangarter B; Knüchel-Clarke R; Rogenhofer M; Wullich B; Hartmann A; Comploj E; Pycha A; Hanspeter E; Pehrke D; Sauter G; Graefen M; Stief C; Haese A
World J Urol; 2015 Jul; 33(7):973-9. PubMed ID: 25682109
[TBL] [Abstract][Full Text] [Related]
15. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
O'Neil LM; Walsh S; Cohen RJ; Lee S
BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
[TBL] [Abstract][Full Text] [Related]
16. Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?
Nguyen DP; Vertosick EA; Sharma V; Corradi RB; Vilaseca A; Takeda T; Sjoberg DD; Benfante N; Fine SW; Reuter VE; Scardino PT; Eastham JA; Karnes RJ; Touijer KA
J Urol; 2018 Jun; 199(6):1502-1509. PubMed ID: 29307681
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: Confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system.
Antunes HP; Parada B; Carvalho J; Eliseu M; Jarimba R; Oliveira R; Tavares-da-Silva E; Figueiredo A
Arch Ital Urol Androl; 2018 Sep; 90(3):191-194. PubMed ID: 30362685
[TBL] [Abstract][Full Text] [Related]
18. Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen.
Greenberg SA; Washington SL; Lonergan PE; Cowan JE; Baskin AS; Nguyen HG; Odisho AY; Simko JP; Carroll PR
J Urol; 2021 Sep; 206(3):706-714. PubMed ID: 33905262
[TBL] [Abstract][Full Text] [Related]
19. Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers.
Iakymenko OA; Lugo I; Briski LM; Nemov I; Punnen S; Kwon D; Pollack A; Stoyanova R; Parekh DJ; Jorda M; Gonzalgo ML; Kryvenko ON
Prostate; 2021 Sep; 81(12):866-873. PubMed ID: 34184782
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
